Hepatitis C Drugs – A Look at Emerging Payment Models and Patient-Centered Outcomes Research

May 15, 2019. . Sponsored by National Academy for State Health Policy
Source: Rural events via the Rural Assistance Center - Category: Rural Health Source Type: events

Related Links:

Is liver stiffness measured by MRE useful for predicting HCC development in patients with chronic hepatitis C who achieved SVR following DAA treatment?Journal of Viral Hepatitis
Source: Medscape Radiology Headlines - Category: Radiology Tags: Gastroenterology Journal Article Source Type: news
Source: Infection and Drug Resistance - Category: Infectious Diseases Tags: Infection and Drug Resistance Source Type: research
In conclusion, until better noninvasive markers for liver fibrosis are developed and validated for HIV-HCV coinfected patients, noninvasive serum markers should be used carefully in this population. PMID: 31320163 [PubMed]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
Authors: Quarleri JF, Oubiña JR Abstract Hepatitis C virus (HCV) is a small, enveloped RNA virus. The number of HCV-infected individuals worldwide is estimated to be approximately 200 million. The vast majority of HCV infections persist, with up to 80% of all cases leading to chronic hepatitis associated with liver fibrosis, cirrhosis, and hepatocellular carcinoma. The interaction between HCV and the host have a pivotal role in viral fitness, persistence, pathogenicity, and disease progression. The control of HCV infection requires both effective innate and adaptive immune responses. The HCV clearance during...
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
Authors: Villar LM, Lampe E, de Almeida AJ, de Paula Scalioni L, Lewis-Ximenez LL, Miguel JC, Del Campo JA, Ranchal I, Villela-Nogueira CA, Romero-Gomez M PMID: 31320161 [PubMed]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
Authors: Basyigit S, Sapmaz F, Kefeli A PMID: 31320160 [PubMed]
Source: Annals of Hepatology - Category: Gastroenterology Tags: Ann Hepatol Source Type: research
In this study, we took advantage of the high prevalence of pharmacologically induced depression in patients treated with IFN-α and ribavirin to test the interest of RNA editing–related biomarkers in white blood cells of patients. In this 16-week longitudinal study, a small cohort of patients was clinically evaluated using standard assessment methods prior to and during antiviral therapy and blood samples were collected to analyse RNA editing modifications. A-I RNA editing activity on the phosphodiesterase 8A (PDE8A) gene, a previously identified RNA editing hotspot in the c ontext of lupus erythematosus, was qu...
Source: Journal of NeuroVirology - Category: Neurology Source Type: research
Publication date: Available online 19 July 2019Source: Journal of Clinical and Experimental HepatologyAuthor(s): Suresh Gorka, Ghulam Mohd Gulzar, Ghulam Nabi Yattoo, Jaswinder Singh Sodhi, Gulzar Ahmad Dar, Mushtaq Ahmad Laway, Saurabh Kaushik, Neeraj Dhar, Syed Mushfiq, Riffat Abdul AzizAbstractBackground/ObjectiveOur data is one of the earliest study from Indian subcontinent on Velpatasvir/Sofosbuvir (VEL/SOF) combination in chronic hepatitis C (CHC). The primary end point was to evaluate the sustained virologic response (SVR-12) in CHC infected patients and to determine its effect in patients with HCV related cirrhosis...
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
In conclusion, aberrantly methylated AURKA and FOS may be potential therapeutic targets for HCV‑positive HCC. PMID: 31322223 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
Conclusions: Pretreatment characteristics differentially predict treatment response for heroin and cocaine use. Similar research in diverse patient groups may aid in the development of personalized treatment combining biologic treatment with targeted psychosocial interventions. PMID: 31315479 [PubMed - as supplied by publisher]
Source: Substance Use and Misuse - Category: Addiction Tags: Subst Use Misuse Source Type: research
More News: Academies | Hepatitis | Hepatitis C | Rural Health